HK2 and neoplasm: The expression and activity of key glycolytic enzymes, such as hexokinase-2 (HK2), glucose transporter type 1 (GLUT1) and pyruvatekinase M (PKM), can affect the glycolysis of tumor cells and thereby affect tumor proliferation [40, 41].